Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Entrenet Nutritionals, Inc.
WARNING LETTER
•Entrenet Nutritionals, Inc.•November 1, 2012

Entrenet Nutritionals, Inc. – FDA Warning Letter, Nov 1, 2012

Record Details

The FDA issued a Warning Letter to Entrenet Nutritionals, Inc. following an October-November 2012 inspection, citing serious violations of dietary supplement CGMP regulations (21 CFR Part 111) and misbranding. Products were deemed adulterated and, in some cases, unapproved new drugs. Specific products (Gone, Cardio Rescue, Arthri-Attack, Complete Food Supreme) were classified as unapproved new drugs due to therapeutic claims on their labels, such as reducing pain or supporting cardiovascular health. Cardio Rescue and Complete Food Supreme were also misbranded for lacking adequate directions for use. CGMP violations included the failure to establish and follow written procedures for quality control operations (material review, disposition, product release), product complaint review and record-keeping, holding and distributing, and handling returned dietary supplements. The FDA emphasized the firm's ultimate responsibility for CGMP compliance as a distributor. Extensive dietary supplement misbranding violations (21 CFR Part 101) affected numerous products, including failures related to product identification as "dietary supplement," "Supplement Facts" labeling, ingredient representation (e.g., Siberian Ginseng), identification of botanical plant parts, serving size, number of servings, name/place of business, net quantity of contents, and adverse event reporting contact information. Entrenet Nutritionals must promptly correct all violations and respond within fifteen working days with detailed corrective actions and a timeline. Non-compliance could lead to regulatory actions like injunction or seizure, and reinspection fees.

Company
Entrenet Nutritionals, Inc.
Inspection date
November 1, 2012
Product type
Drugs
Office
Philadelphia District Office
People
  • Kirk D. Sooter (District Director)
  • Tracy Belcastro
View Company Profile

ID · 6627795f-4ab8-4f74-9b01-cd8b20db0dab

Violation Codes10
21 U.S.C. 34321 U.S.C. 343(q)(5)(F)21 CFR 11121 U.S.C. 342(g)(1)21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(p)21 CFR 10121 U.S.C. 343(s)(2)(B)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Entrenet Nutritionals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.